NIKA PHARMACEUTICALS, INC
Data quality: 83%
NIKA
OTC
Manufacturing
Chemicals
$0.75
$0.00
(0.00%)
Mkt Cap: 785.03 M
Price
$0.75
Mkt Cap
785.03 M
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—
Quick Summary
Key Takeaways
Negative free cash flow of -79,654.0
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
N/A
ROIC-218.55%
Net MarginN/A
Op. MarginN/A
Safety
Debt / Equity
N/A
Current Ratio0.08
Interest CoverageN/A
Valuation
PE (TTM)
-10275.58
Below sector avg (-1.48)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A
Price History
Financial Trends
Peer Comparison
vs Manufacturing sector median (1364 peers)
Peer Comparison
vs Manufacturing sector median (1364 peers)| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -10275.6 | -1.5 |
| P/B | — | 1.6 |
| ROE % | — | -53.5 |
| Net Margin % | — | -41.5 |
| Rev Growth 5Y % | — | 1.8 |
| D/E | — | 0.3 |
Analyst Price Target
No analyst coverage available
Earnings Estimates
No forward estimates available
No quarterly estimates available
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | -76,398.0 |
| ROE | N/A | ROA | -276.64% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -79,654.0 |
| ROIC | -218.55% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 0.08 |
| Interest Coverage | N/A | Asset Turnover | N/A |
| Working Capital | -260,539 | Tangible Book Value | -260,539 |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -10275.58 | Forward P/E | N/A |
| P/B Ratio | N/A | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -0.01% | ||
| Market Cap | 785.03 M | Enterprise Value | 785.31 M |
| Per Share | |||
| EPS (Diluted TTM) | 0.00 | Revenue / Share | N/A |
| FCF / Share | 0.00 | OCF / Share | 0.00 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 104.26% |
| SBC-Adj. FCF | N/A | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2020 |
|---|---|---|---|---|---|
| Revenue | — | 0.0 | 0.0 | 0.0 | — |
| Net Income | -76,398.0 | -95,792.0 | -64,833.0 | -3.18 M | -8,907.0 |
| EPS (Diluted) | 0.00 | 0.00 | — | 0.00 | — |
| Gross Profit | — | — | — | — | — |
| Operating Income | -76,398.0 | -95,792.0 | -64,833.0 | -3.18 M | -8,907.0 |
| EBITDA | — | — | — | — | — |
| R&D Expenses | — | — | — | — | — |
| SG&A Expenses | — | — | — | — | — |
| D&A | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Income Tax | — | — | — | — | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 20,996.0 | 17,934.0 | 19,596.0 | 864.0 | 1,611.0 |
| Total Liabilities | 318,624.0 | 239,164.0 | 101,745.0 | 18,180.0 | 10,518.0 |
| Shareholders' Equity | -297,628.0 | -221,230.0 | -82,149.0 | -17,316.0 | -8,907.0 |
| Total Debt | 318,624.0 | 239,164.0 | — | — | — |
| Cash & Equivalents | 1,889.0 | 2,083.0 | 19,596.0 | 864.0 | — |
| Current Assets | 20,996.0 | 17,934.0 | 19,596.0 | 864.0 | 1,611.0 |
| Current Liabilities | 318,624.0 | 239,164.0 | 101,745.0 | 18,180.0 | — |
{"event":"ticker_viewed","properties":{"ticker":"NIKA","listing_kind":"stock","pathname":"/stocks/nika","exchange":"OTC","country":"US"}}